Rare Disease Trial, Recruiting (NCT06948344)

Rare Disease Trial, Recruiting NCT06948344 Sponsor: Yonsei University Condition: Rare Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06948344 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rare Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 19 years of age or older and are willing and able to give written consent to take part.
You have been diagnosed with cardiomyopathy (a disease affecting the heart muscle) and doctors suspect it may be caused by a genetic (inherited) reason, but the exact cause is unknown.
You have cardiomyopathy and no clear outside cause (such as high blood pressure, heavy alcohol use, or chemotherapy) has been found, and a genetic cause is strongly suspected.
You have previously had genetic testing done but no problem gene was found, and doctors feel a more detailed type of genetic test (whole genome sequencing) may help.
You were diagnosed with cardiomyopathy before the age of 50 with no known contributing factors like high blood pressure or heavy alcohol use, making a genetic cause strongly suspected.
You have a close blood relative (parent, brother, sister, or child) who has been diagnosed with the same type of cardiomyopathy, suggesting it runs in the family.

Who may not be able to join:

You have been confirmed to have cardiomyopathy caused by blocked heart arteries (confirmed through heart imaging showing significant blockage or specific scarring patterns on a heart MRI).
Your heart failure is caused by another known condition, such as a problem with your heart valves or a hormonal/gland-related disease.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06948344

Sponsor: Yonsei University

Phase: Not Applicable

Status: Recruiting

Condition: Rare Disease

More information: https://clinicaltrials.gov/study/NCT06948344

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 19 years of age or older and are willing and able to give written consent to take part.
You have been diagnosed with cardiomyopathy (a disease affecting the heart muscle) and doctors suspect it may be caused by a genetic (inherited) reason, but the exact cause is unknown.
You have cardiomyopathy and no clear outside cause (such as high blood pressure, heavy alcohol use, or chemotherapy) has been found, and a genetic cause is strongly suspected.
You have previously had genetic testing done but no problem gene was found, and doctors feel a more detailed type of genetic test (whole genome sequencing) may help.
You were diagnosed with cardiomyopathy before the age of 50 with no known contributing factors like high blood pressure or heavy alcohol use, making a genetic cause strongly suspected.
You have a close blood relative (parent, brother, sister, or child) who has been diagnosed with the same type of cardiomyopathy, suggesting it runs in the family.

Who may not be able to join:

You have been confirmed to have cardiomyopathy caused by blocked heart arteries (confirmed through heart imaging showing significant blockage or specific scarring patterns on a heart MRI).
Your heart failure is caused by another known condition, such as a problem with your heart valves or a hormonal/gland-related disease.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Yonsei University

Registry

ClinicalTrials.gov

Start date

10 October 2023

Est. completion

30 June 2028

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Establishing genomic profiles of rare inherited cardiomyopathies

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov